High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma
- 5 October 2012
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 426 (4) , 636-642
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Diagnostic and Prognostic Molecular Markers for Renal Cell Carcinoma: A Critical Appraisal of the Current State of Research and Clinical ApplicabilityEuropean Urology, 2009
- Cancer‐specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989‐2005)Cancer, 2008
- Characterization of a neuregulin-1 gene promoter: Positive regulation of type I isoforms by NF-κBBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2008
- The zinc finger repressor, ZBP‐89, recruits histone deacetylase 1 to repress vimentin gene expressionGenes to Cells, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Rising Incidence of Small Renal Masses: A Need to Reassess Treatment EffectJNCI: Journal of the National Cancer Institute, 2006
- Comprehensive analysis of HE4 expression in normal and malignant human tissuesLaboratory Investigation, 2006
- ZBP-89, Sp1, and Nuclear Factor-κB Regulate Epithelial Neutrophil-activating Peptide-78 Gene Expression in Caco-2 Human Colonic Epithelial CellsJournal of Biological Chemistry, 2001
- Transcription Factor ZBP-89 Cooperates with Histone Acetyltransferase p300 during Butyrate Activation of p21 Transcription in Human CellsJournal of Biological Chemistry, 2000
- Overexpression of ZBP-89, a Zinc Finger DNA Binding Protein, in Gastric CancerBiochemical and Biophysical Research Communications, 1997